1、 NCCN Clinical Practice Guidelines in Oncology,Bladder Cancer,version 6.2020—July 16,2020 2、 Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase...
gallbladder cancer, and intrahepatic and extrahepatic cholangiocarcinoma.Guidelines for HCC are consistent with those offered by the EuropeanAssociation for the Study of the Liver/European
* cystoscopy and urine cytology every 3–6 mo for 2 y, then increasing intervals as appropriate *膀胱镜和尿细胞学检查每3–6个月1次共2年a,之后酌情延长间隔 * Consider imaging of upper tract collecting system every 1–2 y a for high-grade tumors *对于高分级肿瘤,考虑上尿路收集系统影像学检...
NCCN 癌症治疗指南:膀胱癌2023(英).pdf,NCCN GUIDELINES FOR PATIENTS® 2023 Bladder Cancer ® NATIONAL COMPREHENSIVE CANCER NETWORK Available online at Presented with support from FOUNDATION NCCN.org/patientguidelines Guiding Treatment. Changing Live
1、 NCCN Clinical Practice Guidelines in Oncology,Bladder Cancer,version 6.2020—July 16,2020 2、 Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study ...
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Bladder Cancer Version 3.2021 — April 22, 2021 NCCN.org NCCN Guidelines for Patients? available at /patients For important information regarding the BCG shortage see MS-10. Also see the AUA For important information regarding the BCG...
The National Comprehensive Cancer Network (NCCN ) makes no representations or warranties of any kind regarding their content, use or application and disclaims any responsibility for their application or use in any way. The NCCN ?Guidelines are copyrighted by National Comprehensive Cancer Network . ...
NCCN 指南 膀胱癌 2.2022 版.pdf,® NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Bladder Cancer Version 2.2022 — May 20, 2022 NCCN.org ® NCCN Guidelines for Patients available at /patients For important information regarding the B
NCCN Guidelines for Treatment of Cancer by Site Acute Myeloid LeukemiaVersion 1.2018 AIDS-Related Kaposi Sarcoma Version 1.2018 Anal Carcinoma Version1.2018 B-Cell Lymphomas Version2.2018 Bladder Cancer Version2.2018 Breast Cancer Version4.2017 Cervical Cancer Version1.2018 ...
NCCN Guidelines Version 4.2020Muscle Invasive Bladder CancerNCCN Guidelines IndexTable of ContentsDiscussion注:除非另有说明,否则所有建议均为 2A 类。临床试验:NCCN 认为任何癌症患者的最佳管理都在临床试验中。特别鼓励参加临床试验。 NCCN Guidelines Version 4.2020Bladder CancerNCCN Guidelines IndexTable of ...